Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

Conditions:   Meibomian Gland Dysfunction;   Blepharitis;   Demodex Infestation Interventions:   Drug: TP-03;   Drug: TP-03 Vehicle Sponsor:   Tarsus Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - July 12, 2022 Category: Research Source Type: clinical trials